Mera Pharmaceuticals, Inc. (OTCPK: MRPI)
Health Care · Biotechnology · US
$0.00
-99.00% today · 0.0% 1Y
Mera Pharmaceuticals, Inc. (OTCPK: MRPI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $537.00 and employs 74 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Mera Pharmaceuticals, Inc. across four factors: quality 33/100, value 25/100. Its strongest factor is quality.
MRPI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $537.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 70.75
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 536.65M
- Employees
- 74
- Next earnings
- —
About Mera Pharmaceuticals, Inc.
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.
- ISIN
- US58732R1032
- Founded
- 1983
- Listed since
- Feb 1, 1995
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Amarantus BioScience Holdings, Inc.OTCPK: AMBS | $630.00 | $0.00 | — |
| Rosetta Genomics Ltd.OTCPK: ROSG.Q | $593.00 | $— | — |
| Adynxx, Inc.OTCPK: ADYX | $581.00 | $— | — |
| GlobeImmune, Inc.OTCPK: GBIM | $575.00 | $— | — |
| Trevena, Inc.OTCPK: TRVN | $479.00 | $0.00 | -95.83% |
| Biora Therapeutics, Inc.OTCPK: BIOR.Q | $442.00 | $0.00 | — |
| Tengion, Inc.OTCPK: TNGN.Q | $402.00 | $— | — |
| IMAC Holdings, Inc.OTCPK: BACK | $379.00 | $0.00 | -83.33% |
Figures last refreshed Oct 18, 2026.